CTKB (Cytek Biosciences) Inventory Turnover: 0.47 (As of Mar. 2026)

What is Cytek Biosciences Inventory Turnover?

Cytek Biosciences CTKB +0.11% 71 Inventory Turnover is 0.47 as of Mar. 2026. GuruFocus rates CTKB with a GF Score™ of 71/100 and a GF Value™ of $5.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Cytek Biosciences's Cost of Goods Sold for the three months ended in Mar. 2026 was $22.9 Mil. Cytek Biosciences's Average Total Inventories for the quarter that ended in Mar. 2026 was $49.1 Mil. Cytek Biosciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.47.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cytek Biosciences's Days Inventory for the three months ended in Mar. 2026 was 195.85.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cytek Biosciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.11.

Cytek Biosciences (NAS:CTKB) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cytek Biosciences's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	49.1095	/	22.881	*	365 / 4
	=	195.85

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cytek Biosciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	49.1095	/	44.135
	=	1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Cytek Biosciences Inventory Turnover Related Terms

Cytek Biosciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Cytek Biosciences's Inventory Turnover can be seen below:

Cytek Biosciences Inventory Turnover Chart

Cytek Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

1.77

1.57

1.53

1.71

2.10

Cytek Biosciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.48	0.46	0.49	0.58	0.47

71GF Score

Cytek Biosciences Inc CTKB

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cytek Biosciences Inventory Turnover Calculation

Cytek Biosciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	97.033	/ (	(43.893	+	48.428)	/	2 )
=	97.033	/	46.1605
=	2.10

Cytek Biosciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	22.881	/ (	(48.428	+	49.791)	/	2 )
=	22.881	/	49.1095
=	0.47

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.47 mean?

Cytek Biosciences (CTKB) has a Inventory Turnover of 0.47 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cytek Biosciences and its competitors.

Is Cytek Biosciences' Inventory Turnover too high?

Cytek Biosciences' current Inventory Turnover is 0.47. Overall, Cytek Biosciences has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Cytek Biosciences' Inventory Turnover compare to BBNX and TCMD?

Cytek Biosciences' Inventory Turnover of 0.47 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cytek Biosciences and its competitors. Cytek Biosciences's current Inventory Turnover is 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cytek Biosciences stock overvalued right now?

Based on GuruFocus' analysis, Cytek Biosciences (CTKB) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.82, compared to a current price of $4.46 — trading 23.4% below its estimated fair value. The current Inventory Turnover is 0.47. Cytek Biosciences' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Cytek Biosciences (CTKB), the current Inventory Turnover is 0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cytek Biosciences (CTKB) Overvalued in 2026?

Based on GuruFocus' analysis, Cytek Biosciences stock appears to be undervalued. The current stock price of $4.46 is trading 23.4% below its estimated GF Value™ of $5.82. GuruFocus considers Cytek Biosciences to be Modestly Undervalued.

Key valuation signals for CTKB:

Inventory Turnover: 0.47
GF Value™: $5.82 vs. price of $4.46 (23.4% below fair value)
GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the CTKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cytek Biosciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies BBNX TCMD NPCE BVS CERS PACB SIBN CATX LAB KIDS ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges 8EQ:Germany

Address 47215 Lakeview Boulevard, Fremont, CA, USA, 94538

Website https://www.cytekbio.com

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

71GF Score

Get the complete analysis for CTKB

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.46

Price

$5.82

GF Value

View CTKB Analysis

See Inventory Turnover data for all stocks →